These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8143597)

  • 1. Dose response for TCDD promotion of hepatocarcinogenesis in rats initiated with DEN: histologic, biochemical, and cell proliferation endpoints.
    Maronpot RR; Foley JF; Takahashi K; Goldsworthy T; Clark G; Tritscher A; Portier C; Lucier G
    Environ Health Perspect; 1993 Dec; 101(7):634-42. PubMed ID: 8143597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats.
    Tritscher AM; Clark GC; Sewall C; Sills RC; Maronpot R; Lucier GW
    Carcinogenesis; 1995 Nov; 16(11):2807-11. PubMed ID: 7586202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocarcinogenesis in female Sprague-Dawley rats following discontinuous treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Walker NJ; Tritscher AM; Sills RC; Lucier GW; Portier CJ
    Toxicol Sci; 2000 Apr; 54(2):330-7. PubMed ID: 10774815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of dose- and time-dependent promotion of four phenotypes of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Sprague-Dawley rats.
    Teeguarden JG; Dragan YP; Singh J; Vaughan J; Xu YH; Goldsworthy T; Pitot HC
    Toxicol Sci; 1999 Oct; 51(2):211-23. PubMed ID: 10543023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis.
    Lucier GW; Tritscher A; Goldsworthy T; Foley J; Clark G; Goldstein J; Maronpot R
    Cancer Res; 1991 Mar; 51(5):1391-7. PubMed ID: 1671757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver.
    Tritscher AM; Goldstein JA; Portier CJ; McCoy Z; Clark GC; Lucier GW
    Cancer Res; 1992 Jun; 52(12):3436-42. PubMed ID: 1596902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on initiation and promotion of GST-P-positive foci in rat liver: A quantitative analysis of experimental data using a stochastic model.
    Luebeck EG; Buchmann A; Stinchcombe S; Moolgavkar SH; Schwarz M
    Toxicol Appl Pharmacol; 2000 Aug; 167(1):63-73. PubMed ID: 10936080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the number and size of hepatic focal lesions following exposure to 2,3,7,8-TCDD.
    Portier CJ; Sherman CD; Kohn M; Edler L; Kopp-Schneider A; Maronpot RM; Lucier G
    Toxicol Appl Pharmacol; 1996 May; 138(1):20-30. PubMed ID: 8658509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of hepatic 8-oxo-deoxyguanosine adducts by 2,3,7,8-tetrachlorodibenzo-p-dioxin in Sprague-Dawley rats is female-specific and estrogen-dependent.
    Wyde ME; Wong VA; Kim AH; Lucier GW; Walker NJ
    Chem Res Toxicol; 2001 Jul; 14(7):849-55. PubMed ID: 11453731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin and 17beta-estradiol in male Sprague-Dawley rats.
    Wyde ME; Cambre T; Lebetkin M; Eldridge SR; Walker NJ
    Toxicol Sci; 2002 Aug; 68(2):295-303. PubMed ID: 12151625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in kinetics of induction and reversibility of TCDD-induced changes in cell proliferation and CYP1A1 expression in female Sprague-Dawley rat liver.
    Walker NJ; Miller BD; Kohn MC; Lucier GW; Tritscher AM
    Carcinogenesis; 1998 Aug; 19(8):1427-35. PubMed ID: 9744539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCDD-mediated changes in hepatic epidermal growth factor receptor may be a critical event in the hepatocarcinogenic action of TCDD.
    Sewall CH; Lucier GW; Tritscher AM; Clark GC
    Carcinogenesis; 1993 Sep; 14(9):1885-93. PubMed ID: 8403215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin and phenobarbital-induced promotion of hepatocarcinogenesis in rats by the type of diet and vitamin A deficiency.
    Flodström S; Busk L; Kronevi T; Ahlborg UG
    Fundam Appl Toxicol; 1991 Feb; 16(2):375-91. PubMed ID: 2055368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine.
    Pitot HC; Goldsworthy T; Campbell HA; Poland A
    Cancer Res; 1980 Oct; 40(10):3616-20. PubMed ID: 6108157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (525):1-198. PubMed ID: 17160103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains.
    Viluksela M; Bager Y; Tuomisto JT; Scheu G; Unkila M; Pohjanvirta R; Flodström S; Kosma VM; Mäki-Paakkanen J; Vartiainen T; Klimm C; Schramm KW; Wärngård L; Tuomisto J
    Cancer Res; 2000 Dec; 60(24):6911-20. PubMed ID: 11156390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined supplementation of vanadium and beta-carotene suppresses placental glutathione S-transferase-positive foci and enhances antioxidant functions during the inhibition of diethylnitrosamine-induced rat liver carcinogenesis.
    Chattopadhyay MB; C B MK; Kanna PS; Ray RS; Roy S; Chatterjee M
    J Gastroenterol Hepatol; 2004 Jun; 19(6):683-93. PubMed ID: 15151625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.